https://www.selleckchem.com/products/azd2014.html
that can be achieved in this group. Evidence on treatment effects in newly diagnosed women is urgently needed. Applying the WHO 2013 criteria would result in a substantial increase in GDM diagnoses. Newly diagnosed women are at increased risk for pregnancy adverse outcomes. This risk, however, seems to be lower than those identified by the WHO 1999 criteria. This could potentially influence the treatment effect that can be achieved in this group. Evidence on treatment effects in newly diagnosed women is urgently needed.Cardiovascular au
Like
Comment
Share
